Peripheral blood count abnormalities among patients with hepatitis C in the United States

被引:51
|
作者
Streiff, MB
Mehta, S
Thomas, DL
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1053/jhep.2002.32486
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
An estimated 2.7 million people in the United States are infected with the hepatitis C virus (HCV), yet the influence of HCV infection on the peripheral blood count remains unknown. To investigate the prevalence of low peripheral blood counts among HCV-infected adults in the United States general population, we analyzed data collected in the third National Health and Nutrition Examination Survey (NHANES III). The study population consisted of 16,196 individuals age 18 or older who had peripheral blood counts and data on HCV infection. The lowest fifth percentile of each component of the peripheral blood was design nated a priori as being low. HCV infection was assessed by antibody reactivity. HCV antibody-positive individuals were 3-fold more likely to have low neutrophil counts (HCV positive, 9% vs. HCV negative, 3%, P <.0001) and 2.6-fold more likely to have low platelet counts (HCV positive, 13% vs. HCV negative, 5%, P <.0001) independent of other evaluated factors. HCV infection was observed in more than 20% of persons with neutrophil counts below 1.0 X 10(9)/L or platelet counts less than 100 X 10(9)/L. No association was detected between anti-HCV status and anemia or other peripheral blood cell components. In conclusion, HCV-infected persons in the general population of the United States are more likely to have low neutrophil and platelet counts, and HCV testing should be considered for persons with unexplained neutrophil counts below 1.0 X 10(9)/L or platelet counts less than 100 X 10(9)/L. Alternate causes of anemia should be considered for HCV-infected persons with low red blood cell counts.
引用
收藏
页码:947 / 952
页数:6
相关论文
共 50 条
  • [41] Toward the elimination of hepatitis C in the United States
    Saab, Sammy
    Le, Long
    Saggi, Satvir
    Sundaram, Vinay
    Tong, Myron J.
    HEPATOLOGY, 2018, 67 (06) : 2449 - 2459
  • [42] Hepatocellular carcinoma and hepatitis C in the United States
    El-Serag, HB
    HEPATOLOGY, 2002, 36 (05) : S74 - S83
  • [43] The epidemiology of hepatitis C infection in the United States
    Rustgi, Vinod K.
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (07) : 513 - 521
  • [44] Hepatitis C virus load and survival among injection drug users in the United States
    Hisada, M
    Chatterjee, N
    Kalaylioglu, Z
    Battjes, RJ
    Goedert, JJ
    HEPATOLOGY, 2005, 42 (06) : 1446 - 1452
  • [45] Low Insurance Coverage Among Hepatitis C (HCV)-Positive Individuals in the United States
    Stepanova, Maria
    Kanwal, Fasiha
    El-Serag, Hashem
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2011, 140 (05) : S894 - S894
  • [46] Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States
    Bini, EJ
    McGready, J
    HEPATOLOGY, 2005, 41 (05) : 1029 - 1036
  • [47] Hepatitis c therapeutic management patterns among gastroenterologists in the United States: A national survey
    Hurley, SP
    Hepburn, M
    Russo, M
    Lawitz, E
    GASTROENTEROLOGY, 2004, 126 (04) : A430 - A430
  • [48] Disparities in hepatitis C virus infection screening among Baby Boomers in the United States
    Nili, Mona
    Luo, Lucy
    Feng, Xue
    Chang, Jongwha
    Tan, Xi
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (12) : 1341 - 1347
  • [49] Hepatitis C Cascades: Data to Inform Hepatitis C Elimination in the United States
    Montgomery, Martha P.
    Randall, Liisa M.
    Morrison, Monica
    Gupta, Neil
    Doshani, Mona
    Teshale, Eyasu
    PUBLIC HEALTH REPORTS, 2023,
  • [50] Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
    Saab, Sammy
    Jimenez, Melissa
    Fong, Tiffany
    Wu, Crystal
    Bau, Sherona
    Jamal, Zoha
    Grotts, Jonathan
    Elashoff, David
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2016, 4 (02) : 76 - 82